Search research articles
Contact Us
Filters
Showing results (1-10 of 63) with videos related to
Page
of 7
Sort By:
Innovations in Clinical Neuroscience
|
July 15, 2016
ASPECT-R-A Tool to Rate the Pragmatic and Explanatory Characteristics of a Clinical Trial Design
Larry D Alphs, Cynthia A Bossie
Schizophrenia Research
|
January 21, 2006
Measuring remission in schizophrenia: response to Sethuraman et al., 2005
Mary Kujawa, Cynthia A Bossie, Robert A Lasser
The American Journal of Psychiatry
|
May 2, 2006
New-onset tardive dyskinesia in patients with first-episode psychosis receiving risperidone or haloperidol
Georges M Gharabawi, Cynthia A Bossie, Young Zhu
International Clinical Psychopharmacology
|
June 8, 2015
Long-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designs
Cynthia A Bossie, Larry D Alphs, Christoph U Correll
International Clinical Psychopharmacology
|
June 18, 2004
Improvements in stable patients with psychotic disorders switched from oral conventional antipsychotics therapy to long-acting risperidone
Jim van Os, Cynthia A Bossie, Robert A Lasser
International Clinical Psychopharmacology
|
June 4, 2005
Lack of impact of race on the efficacy and safety of long-acting risperidone versus placebo in patients with schizophrenia or schizoaffective disorder
Natalie Ciliberto, Cynthia A Bossie, Ronald Urioste, et al.
Neuropsychiatric Disease and Treatment
|
February 3, 2009
Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia
Ibrahim Turkoz, Cynthia A Bossie, Bryan Dirks, et al.
International Clinical Psychopharmacology
|
January 27, 2010
Risperidone long-acting therapy in stable patients with recently diagnosed schizophrenia
Wayne Macfadden, Cynthia A Bossie, Ibrahim Turkoz, et al.
Innovations in Clinical Neuroscience
|
May 26, 2016
The Direct and Indirect Effects of Paliperidone Extended-release on Depressive Symptoms in Schizoaffective Disorder: A Path Analysis
Ibrahim Turkoz, Dong-Jing Fu, Cynthia A Bossie, et al.
Journal of Psychosocial Nursing and Mental Health Services
|
November 1, 2019
Long-Acting Injectable Antipsychotics
Karen Johnston, Jennifer Kern Sliwa, Cynthia A Bossie, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 63) with videos related to
Sort By:
Page
of 7
Innovations in Clinical Neuroscience
|
July 15, 2016
ASPECT-R-A Tool to Rate the Pragmatic and Explanatory Characteristics of a Clinical Trial Design
Larry D Alphs, Cynthia A Bossie
Schizophrenia Research
|
January 21, 2006
Measuring remission in schizophrenia: response to Sethuraman et al., 2005
Mary Kujawa, Cynthia A Bossie, Robert A Lasser
The American Journal of Psychiatry
|
May 2, 2006
New-onset tardive dyskinesia in patients with first-episode psychosis receiving risperidone or haloperidol
Georges M Gharabawi, Cynthia A Bossie, Young Zhu
International Clinical Psychopharmacology
|
June 8, 2015
Long-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designs
Cynthia A Bossie, Larry D Alphs, Christoph U Correll
International Clinical Psychopharmacology
|
June 18, 2004
Improvements in stable patients with psychotic disorders switched from oral conventional antipsychotics therapy to long-acting risperidone
Jim van Os, Cynthia A Bossie, Robert A Lasser
International Clinical Psychopharmacology
|
June 4, 2005
Lack of impact of race on the efficacy and safety of long-acting risperidone versus placebo in patients with schizophrenia or schizoaffective disorder
Natalie Ciliberto, Cynthia A Bossie, Ronald Urioste, et al.
Neuropsychiatric Disease and Treatment
|
February 3, 2009
Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia
Ibrahim Turkoz, Cynthia A Bossie, Bryan Dirks, et al.
International Clinical Psychopharmacology
|
January 27, 2010
Risperidone long-acting therapy in stable patients with recently diagnosed schizophrenia
Wayne Macfadden, Cynthia A Bossie, Ibrahim Turkoz, et al.
Innovations in Clinical Neuroscience
|
May 26, 2016
The Direct and Indirect Effects of Paliperidone Extended-release on Depressive Symptoms in Schizoaffective Disorder: A Path Analysis
Ibrahim Turkoz, Dong-Jing Fu, Cynthia A Bossie, et al.
Journal of Psychosocial Nursing and Mental Health Services
|
November 1, 2019
Long-Acting Injectable Antipsychotics
Karen Johnston, Jennifer Kern Sliwa, Cynthia A Bossie, et al.
Page
of 7